Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

NARecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Levofloxacin

Levofloxacin is a quinolone antibiotics and newly identified neuro-protective agent.

DRUG

Levofloxacin simulant

Levofloxacin simulant is placebo.

Trial Locations (1)

RECRUITING

First Hospital of Jilin University, Changchun

All Listed Sponsors

lead

Yi Yang

OTHER